Ill. Jury Finds For AbbVie In AndroGel Bellwether Trial
An Illinois federal jury on Tuesday sided with AbbVie Inc. in the fifth bellwether trial in multidistrict litigation over its testosterone replacement therapy drug AndroGel, finding that the drug didn't cause...To view the full article, register now.
Already a subscriber? Click here to view full article